1. Home
  2. ETON vs CCG Comparison

ETON vs CCG Comparison

Compare ETON & CCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETON
  • CCG
  • Stock Information
  • Founded
  • ETON 2017
  • CCG 2014
  • Country
  • ETON United States
  • CCG China
  • Employees
  • ETON N/A
  • CCG N/A
  • Industry
  • ETON Biotechnology: Pharmaceutical Preparations
  • CCG
  • Sector
  • ETON Health Care
  • CCG
  • Exchange
  • ETON Nasdaq
  • CCG Nasdaq
  • Market Cap
  • ETON 388.3M
  • CCG 64.4M
  • IPO Year
  • ETON 2018
  • CCG N/A
  • Fundamental
  • Price
  • ETON $14.38
  • CCG $0.77
  • Analyst Decision
  • ETON Strong Buy
  • CCG Buy
  • Analyst Count
  • ETON 3
  • CCG 1
  • Target Price
  • ETON $29.67
  • CCG $350.00
  • AVG Volume (30 Days)
  • ETON 631.6K
  • CCG 123.4K
  • Earning Date
  • ETON 08-07-2025
  • CCG 08-28-2025
  • Dividend Yield
  • ETON N/A
  • CCG N/A
  • EPS Growth
  • ETON N/A
  • CCG N/A
  • EPS
  • ETON N/A
  • CCG N/A
  • Revenue
  • ETON $48,327,000.00
  • CCG $475,831,129.00
  • Revenue This Year
  • ETON $103.21
  • CCG N/A
  • Revenue Next Year
  • ETON $51.34
  • CCG $7.06
  • P/E Ratio
  • ETON N/A
  • CCG N/A
  • Revenue Growth
  • ETON 40.88
  • CCG 5.20
  • 52 Week Low
  • ETON $3.25
  • CCG $0.56
  • 52 Week High
  • ETON $21.48
  • CCG $1.54
  • Technical
  • Relative Strength Index (RSI)
  • ETON 42.09
  • CCG 46.74
  • Support Level
  • ETON $13.78
  • CCG $0.74
  • Resistance Level
  • ETON $16.27
  • CCG $0.82
  • Average True Range (ATR)
  • ETON 0.80
  • CCG 0.04
  • MACD
  • ETON 0.15
  • CCG 0.00
  • Stochastic Oscillator
  • ETON 38.05
  • CCG 39.15

About ETON Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.

About CCG Cheche Group Inc.

Cheche Group Inc is engaged in the operation of providing insurance transaction services, Software-as-a-Service (SaaS) services and other services in China.. It is China's independent technology-empowered platform for auto insurance transaction services by digital auto insurance transaction premiums and insurance technology companies. The company has reshaped the traditional auto insurance distribution and services value chain to create a digital platform by improving operational efficiencies, reducing transaction costs, and expanding distribution channels. Its business scope ranges from digital insurance transactions, SaaS platforms for insurance intermediaries, AI-driven insurance pricing and underwriting services, auto insurance services for new energy vehicle (NEV) manufacturers, etc.

Share on Social Networks: